Main Article Content



  1. The gold standard therapy of hypospadias is reconstructive surgery.
  2. Glans diameter and penile length are factors influencing urethroplasty outcomes.
  3. Many studies are being conducted to investigate various methods of increasing the size and diameter of the penis prior to the operation in order to reduce complications. 
  4. Preoperative testosterone hormonal therapy is able to reduce overall complication and urethrocutaneous fistula in hypospadias patient undergoing urethroplasty.


The gold standard of treatment for hypospadias patients is reconstructive surgery. The result and post-operative complication of urethroplasty were affected by glans diameter and penile length. Pre-operative testosterone administration, both parenterally or topically, has become one of the main interests to increase the size and diameter of penis to minimize post-operative complications. However, there has not been enough evidence to justify this recommendation. Therefore, we aimed to perform a systematic review and meta-analysis to evaluate the role of pre-operative testosterone to prevent postoperative complications after urethroplasty in hypospadias patients. Online databases of Medline, Scopus and Embase were searched until October 2021 to identify RCT studies evaluating the effect of testosterone hormone therapy in reducing post-operative complication on hypospadias patient undergoing urethroplasty. Data analysis was performed using RevMan 5.4. A total of 4 RCTs were included in the analysis of this study with the total of 211 patients. Pre-operative testosterone hormonal therapy significantly reduced the overall complications group (OR=0.17; 95% CI=0.04, 0.77; p=0.02), post-operative urethrocutaneous fistula (OR=0.4, 95% CI=0.19, 0.83, p=0.01). Finally, there was no significant effect on the incidence of dehiscence and meatal stenosis with OR of 0.59, 95% CI=0.23, 1.54, p = 0.28, and 0.277; 95% CI=0.04, 1.65; p=0.16, respectively. Pre-operative testosterone hormonal therapy could reduce overall complication and urethrocutaneous fistula in hypospadias patients undergoing urethroplasty. 


Urethroplasty hypospadia hormonal therapy health risk

Article Details

How to Cite
Ramadhani, M. Z., & Renaldo, J. (2022). Pre-Operative Hormonal Administration in Hypospadias Patients Undergoing Urethroplasty. Folia Medica Indonesiana, 58(1), 80–87.


  1. Ahmad R, Chana R, Ali S, et al (2011). Role of parenteral testosterone in hypospadias: A study from a teaching hospital in India. Urol. Ann. 3, 138–140.
  2. Asgari S, Safarinejad M, Poorreza F, et al (2015). The effect of parenteral testosterone administration prior to hypospadias surgery: A prospective, randomized and controlled study. J. Pediatr. Urol. 11, 1-6.
  3. Bahadir G, Ergun E, Telli O, et al (2016). Hormone therapy in hypospadias surgery: A survey on the current practice in Turkey. Turkish J. Med. Sci. 46, 1624–1628.
  4. Bastos A, Oliveira L, Ferrarez C, et al (2011). Structural study of prepuce in hypospadias—does topical treatment with testosterone produce alterations in prepuce vascularization? J. Urol. 185, 2474–2478.
  5. Bush N, Villanueva C, Snodgrass W (2015). Glans size is an independent risk factor for urethroplasty complications after hypospadias repair. J. Pediatr. Urol. 11, 1–5.
  6. Chao M, Zhang Y, Liang C (2017). Impact of preoperative hormonal stimulation on postoperative complication rates after hypospadias repair: a meta-analysis. Minerva Urol. e Nefrol. - Ital. J. Urol. Nephrol. 69, 253–261.
  7. Chen C, Gong C-X, Zhang W-P (2015). Effects of oral testosterone undecanoate treatment for severe hypospadias. Int. Urol. Nephrol. 47, 875–880.
  8. Costa E, Fraga J, Salle J, et al (2021). Does parental opinion differ from the health care team regarding cosmesis after hypospadias repair? Rev. Assoc. Med. Bras. 67, 33–38.
  9. Gorduza D, Gay C-L, Silva E, et al (2011). Does androgen stimulation prior to hypospadias surgery increase the rate of healing complications? - A preliminary report. J. Pediatr. Urol. 7, 158–161.
  10. Kaya C, Bektic J, Radmayr C, et al (2008). The efficacy of dihydrotestosterone transdermal gel before primary hypospadias surgery: A prospective, controlled, randomized study. J. Urol. 179, 684–688.
  11. Kaya C, Radmayr C (2014). The role of pre-operative androgen stimulation in hypospadias surgery. Transl. Androl. Urol. 3, 340–346.
  12. Krishnan A, Chagani S, Rohl A (2016). Preoperative testosterone therapy prior to surgical correction of hypospadias: a review of the literature. Cureus 8, 1–6.
  13. Lucas J, Hightower T, Weiss D, et al (2020). Time to complication detection after primary pediatric hypospadias repair: A large, single center, retrospective cohort analysis. J. Urol. 204, 338–344.
  14. Menon P, Rao K, Handu A, et al (2017). Outcome of urethroplasty after parenteral testosterone in children with distal hypospadias. J. Pediatr. Urol. 13, 1–7.
  15. Mohammadipour A, Hiradfar M, Sharifabad P, et al (2020). Pre-operative hormone stimulation in hypospadias repair: A facilitator or a confounder. J. Pediatr. Urol. 16, 1–7.
  16. Netto J, Ferrarez C, Leal A, et al (2013). Hormone therapy in hypospadias surgery: A systematic review. J. Pediatr. Urol. 9, 971–979.
  17. Perlmutter A, Morabito R, Tarry W (2006). Impact of patient age on distal hypospadias repair: A surgical perspective. Urology 68, 648–651.
  18. Ru W, Tang D, Wu D, et al (2021). Identification of risk factors associated with numerous reoperations following primary hypospadias repair. J. Pediatr. Urol. 17, 1–5.
  19. Satav V, Sabale V, Kankalia S, et al (2015). Use of parenteral testosterone in hypospadias cases. Med. J. Dr. D.Y. Patil Vidyapeeth 8, 495–498.
  20. Springer A, Heijkant M, Baumann S (2016). Worldwide prevalence of hypospadias. J. Pediatr. Urol. 12, 1–7.
  21. Wong N, Braga L (2015). The influence of pre-operative hormonal stimulation on hypospadias repair. Front. Pediatr. 3, 1–5.
  22. Wright I, Cole E, Farrokhyar F, et al (2013). Effect of preoperative hormonal stimulation on postoperative complication rates after proximal hypospadias repair: A systematic review. J. Urol. 190, 652–659.
  23. Yu X, Nassar N, Mastroiacovo P, et al (2019). Hypospadias prevalence and trends in international birth defect surveillance systems. Eur. Urol. 76, 482–490.